GE HealthCare Expands Access to Cardiac PET with Flurpiridaz F 18
New tracer Flyrcado (flurpiridaz F 18)—a PET myocardial perfusion imaging (MPI) agent developed for use in patients with known or suspected CAD—gains Medicare and commercial coverage.